- Home
- PSMT vs XENE Comparison
PSMT vs XENE Comparison
Compare PSMT & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSMT
- XENE
- Stock Information
- Founded
- PSMT 1994
- XENE 1996
- Country
- PSMT United States
- XENE Canada
- Employees
- PSMT N/A
- XENE N/A
- Industry
- PSMT Department/Specialty Retail Stores
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- PSMT Consumer Discretionary
- XENE Health Care
- Exchange
- PSMT Nasdaq
- XENE Nasdaq
- Market Cap
- PSMT 3.2B
- XENE 2.9B
- IPO Year
- PSMT 1997
- XENE 2014
- Fundamental
- Price
- PSMT $116.79
- XENE $36.70
- Analyst Decision
- PSMT
- XENE Strong Buy
- Analyst Count
- PSMT 0
- XENE 11
- Target Price
- PSMT N/A
- XENE $52.73
- AVG Volume (30 Days)
- PSMT 213.5K
- XENE 636.6K
- Earning Date
- PSMT 10-30-2025
- XENE 11-11-2025
- Dividend Yield
- PSMT 1.06%
- XENE N/A
- EPS Growth
- PSMT 15.87
- XENE N/A
- EPS
- PSMT 4.75
- XENE N/A
- Revenue
- PSMT $5,165,164,000.00
- XENE $7,500,000.00
- Revenue This Year
- PSMT $9.61
- XENE N/A
- Revenue Next Year
- PSMT $9.58
- XENE $207.88
- P/E Ratio
- PSMT $24.97
- XENE N/A
- Revenue Growth
- PSMT 7.47
- XENE N/A
- 52 Week Low
- PSMT $81.25
- XENE $26.74
- 52 Week High
- PSMT $120.99
- XENE $46.00
- Technical
- Relative Strength Index (RSI)
- PSMT 62.13
- XENE 49.37
- Support Level
- PSMT $108.60
- XENE $35.60
- Resistance Level
- PSMT $120.99
- XENE $39.55
- Average True Range (ATR)
- PSMT 2.90
- XENE 1.04
- MACD
- PSMT 0.78
- XENE -0.49
- Stochastic Oscillator
- PSMT 70.25
- XENE 25.94
About PSMT PriceSmart Inc.
Pricesmart Inc is principally engaged in operating U.S.-style membership shopping warehouse clubs that offer consumer goods at low prices. The company is headquartered in San Diego, California, United States, and operates stores in the Caribbean, Costa Rica, Panama, and other regions. The company's revenue consists of net warehouse club sales from merchandise sales, membership income from annual membership fees, export sales, and other income. Its operations consist of four reportable segments; Central America, the Caribbean, Colombia, and the United States. A majority of the company's revenue is derived from Central America.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.